Australia - engleză - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 20 mg - tablet, film coated - excipient ingredients: hypromellose; iron oxide red; titanium dioxide; croscarmellose sodium; sodium lauryl sulfate; microcrystalline cellulose; lactose monohydrate; purified talc; macrogol 4000 - rivaroxaban is indicated for:,? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 15 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; magnesium stearate; titanium dioxide; lactose monohydrate; iron oxide red; croscarmellose sodium; macrogol 4000; microcrystalline cellulose; hypromellose - rivaroxaban is indicated for:,? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; iron oxide red; sodium lauryl sulfate; macrogol 4000; croscarmellose sodium; titanium dioxide; hypromellose; microcrystalline cellulose - rivaroxaban is indicated for:,? prevention of venous thromboembolism (vte) in adult patients who have undergone major orthopaedic surgery of the lower limbs (elective total hip replacement, treatment for up to 5 weeks; elective total knee replacement, treatment for up to 2 weeks).

Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dr deb the travel doctor pty ltd - permethrin (25:75::cis:trans) - insecticide - fabric (cotton) - repellant treatment | mosquito nets - repellant treatment | cotton blend fabric | cotton blend net | cotton ne - insect | mosquito | adult mosquitoes

Israel - engleză - Ministry of Health

rafa laboratories ltd - ursodeoxycholic acid - capsules - ursodeoxycholic acid 250 mg - ursodeoxycholic acid - ursodeoxycholic acid - treatment of chronic liver diseases primary biliary cirrhosis & primary sclerosing cholangitis.

Israel - engleză - Ministry of Health

rafa laboratories ltd - ursodeoxycholic acid - film coated tablets - ursodeoxycholic acid 500 mg - ursodeoxycholic acid - ursodeoxycholic acid - for the symptomatic treatment of primary biliary cirrhosis (pbc), in patients without decompensated hepatic cirrhosis.

Israel - engleză - Ministry of Health

rafa laboratories ltd - budesonide - capsules - budesonide 3 mg - budesonide - budesonide - acute mild to moderate crohn’s disease with involvement of the ileum (twisted intestine) and/or ascending colon (part of large bowel). collagenous colitis.autoimmune hepatitis.

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

dr. b. scheffler nachf gmbh & co. kg - ascorbic acid - tablets effervescent - 1000 milligram

Regatul Unit - engleză - myHealthbox

dr. reddy’s laboratories (uk) ltd. - bosentan - film-coated tablet - 62.5mg - other antihypertensives - treatment of pulmonary arterial hypertension (pah) to improve exercise capacity and symptoms in patients with who functional class iii. efficacy has been shown in: • primary (idiopathic and heritable) pulmonary arterial hypertension • pulmonary arterial hypertension secondary to scleroderma without significant interstitial pulmonary disease • pulmonary arterial hypertension associated with congenital systemic-topulmonary shunts and eisenmenger’s physiology

Regatul Unit - engleză - myHealthbox

dr. reddy’s laboratories (uk) ltd. - bosentan - film-coated tablet - 125mg - other antihypertensives - treatment of pulmonary arterial hypertension (pah) to improve exercise capacity and symptoms in patients with who functional class iii. efficacy has been shown in: • primary (idiopathic and heritable) pulmonary arterial hypertension • pulmonary arterial hypertension secondary to scleroderma without significant interstitial pulmonary disease • pulmonary arterial hypertension associated with congenital systemic-topulmonary shunts and eisenmenger’s physiology